Great Point Partners’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-977,647
Closed -$11.7M 34
2020
Q4
$11.7M Sell
977,647
-570,832
-37% -$6.75M 1.91% 21
2020
Q3
$15.5M Sell
1,548,479
-534,362
-26% -$6.43M 1.39% 18
2020
Q2
$21.8M Hold
2,082,841
1.74% 17
2020
Q1
$22.3M Sell
2,082,841
-18,100
-0.9% -$219K 2.33% 16
2019
Q4
$33.3M Buy
2,100,941
+34,900
+2% +$374K 2.9% 14
2019
Q3
$16.2M Buy
2,066,041
+389,791
+23% +$3.46M 1.49% 21
2019
Q2
$17.7M Buy
+1,676,250
New +$17.2M 1.97% 15

Other funds holding PRTA

Great Point Partners's PRTA Position: Q1 2021 in Review

Great Point Partners sold out of Prothena Corp (PRTA) in Q1 2021, closing a stake of 977,647 shares — an estimated $11.7M sold.

Great Point Partners first reported a position in PRTA in Q2 2019 and held it in 7 quarters. The position peaked at $33.3M in Q4 2019. 146 funds tracked by Wall St. Rank hold PRTA as of Q1 2021.

  • Great Point Partners reported no remaining Prothena Corp position as of Q1 2021 after selling out during the quarter.
  • Great Point Partners sold 977,647 Prothena Corp shares in Q1 2021, an estimated $11.7M.
  • Great Point Partners first reported a position in Prothena Corp in Q2 2019 and held it in 7 quarters.
  • Great Point Partners's Prothena Corp position peaked at $33.3M in Q4 2019.
  • 146 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2021.

Based on Great Point Partners's 13F filing for Q1 2021, filed 17 May 2021.